DUCA, LEONARDO
 Distribuzione geografica
Continente #
NA - Nord America 897
AS - Asia 868
EU - Europa 481
SA - Sud America 111
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 12
Totale 2.479
Nazione #
US - Stati Uniti d'America 850
SG - Singapore 400
IT - Italia 182
CN - Cina 153
RU - Federazione Russa 107
VN - Vietnam 90
BR - Brasile 88
HK - Hong Kong 68
BD - Bangladesh 63
JP - Giappone 37
DE - Germania 36
GB - Regno Unito 30
FI - Finlandia 24
IN - India 24
CA - Canada 23
PL - Polonia 16
SE - Svezia 16
NL - Olanda 15
MX - Messico 13
AT - Austria 12
AR - Argentina 11
ES - Italia 10
TR - Turchia 7
IE - Irlanda 6
CZ - Repubblica Ceca 5
FR - Francia 5
LT - Lituania 5
EC - Ecuador 4
JM - Giamaica 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
ID - Indonesia 3
IQ - Iraq 3
PK - Pakistan 3
PY - Paraguay 3
BE - Belgio 2
CH - Svizzera 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
NI - Nicaragua 2
PH - Filippine 2
RS - Serbia 2
TN - Tunisia 2
UA - Ucraina 2
VE - Venezuela 2
ZM - Zambia 2
AL - Albania 1
AM - Armenia 1
CO - Colombia 1
CR - Costa Rica 1
GE - Georgia 1
GR - Grecia 1
KE - Kenya 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.369
Città #
Singapore 244
San Jose 136
Ashburn 76
Rome 69
Hong Kong 65
Beijing 62
Council Bluffs 54
Los Angeles 45
Tokyo 37
New York 35
Santa Clara 33
Ho Chi Minh City 32
Hanoi 22
Buffalo 20
Engelhard 19
Helsinki 19
Milan 17
Orem 15
Dallas 14
Fairfield 13
Montreal 13
Munich 13
The Dalles 13
Moscow 12
Nuremberg 12
Chandler 10
Warsaw 10
Frankfurt am Main 9
Mexico City 9
St. George 9
Wilmington 9
Chicago 8
Naples 7
Poplar 7
Redondo Beach 7
Amsterdam 6
Brooklyn 6
Houston 6
Suzhou 6
Chennai 5
Denver 5
London 5
Stockholm 5
São Paulo 5
Toronto 5
Vienna 5
Ann Arbor 4
Brno 4
Chandigarh 4
Lappeenranta 4
Manchester 4
Seattle 4
Belgrade 3
Boardman 3
Caxias do Sul 3
City of London 3
Dublin 3
Gdynia 3
Haiphong 3
Hải Dương 3
Kingston 3
Marano di Napoli 3
Mumbai 3
New Delhi 3
Palermo 3
Phoenix 3
Queens 3
San Francisco 3
São Luís 3
Tampa 3
Taranto 3
Thrissur 3
Amman 2
Ancona 2
Ankara 2
Baghdad 2
Bari 2
Belo Horizonte 2
Bengaluru 2
Biên Hòa 2
Boston 2
Brasília 2
Brussels 2
Buenos Aires 2
Carapicuíba 2
Catania 2
Charleston 2
Conselheiro Lafaiete 2
Conway 2
Detroit 2
Dhaka 2
Eagleville 2
Elk Grove Village 2
Genzano di Roma 2
Ha Long 2
Helena 2
Jacksonville 2
Jakarta 2
Lahore 2
Lake City 2
Totale 1.374
Nome #
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg structural stability in the setting of HBeAg-negative chronic HBV genotype-D infection 167
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 156
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 155
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 101
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 95
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli 92
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response 92
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 90
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 90
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. 89
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli 83
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. 82
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 80
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 80
Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa 79
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL 79
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 76
Heterogeneity in the diagnostic sensitivities of HDV RNA quantification assays used in clinical practice in Italy: data from the first national quality control multicenter study. 75
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 75
Heterogeneity in the diagnostic performances of HDV RNA quantification assays used in clinical practice in Italy: results from a national quality control multicenter study. 72
KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 69
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks 69
Total HIV DNA and cell-associated HIV RNA viral reservoirs in PBMCs and GALT in patients on triple-ART and switching to dual-ART regimens. 68
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 61
Different diagnostic performances of HDV RNA quantification assays used in clinical practicein Italy: results from a national quality control multicenter study. 59
HBs isoforms as innovative biomarkers in predicting virological response in chronic hepatitis delta patients treated with bulevirtide monotherapy. 53
Kinetics of the three HBsAg forms along with HDV-RNA predict virological and biochemical responses in chronic hepatitis delta patients treated with bulevirtide for 48 weeks. 53
The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks. 46
HBs isoforms can play a role in predicting virological response in patients with chronic hepatitis delta under bulevirtide monotherapy. 45
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. 34
Chronic HDV Infection Shows Higher HBsAg Isoform Levels than HBV Infection, Paralleling HDV Replicative Activity 14
Totale 2.479
Categoria #
all - tutte 9.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.786


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202221 0 0 0 3 0 3 4 0 7 1 0 3
2022/202330 2 2 7 1 3 4 2 5 4 0 0 0
2023/2024127 2 0 1 6 1 4 2 0 0 92 4 15
2024/2025538 25 110 80 29 26 56 58 14 42 24 42 32
2025/20261.598 200 74 129 182 167 60 179 186 154 94 66 107
2026/2027128 73 55 0 0 0 0 0 0 0 0 0 0
Totale 2.479